IntegraMed(R) Added to Russell Microcap(R) Index

IntegraMed America, Inc. (Nasdaq: INMD) today announced that it has been selected for inclusion in the Russell Microcap Index. The Russell family of U.S. indexes is designed to be a comprehensive representation of the investable U.S. equity market. The Russell Microcap Index measures performance of the microcap segment. On June 22, 2007, the Russell Investment Group announced changes to its Microcap Index, including the addition of IntegraMed America. As stated on their website (see www.russell.com) Russell provides "the leading U.S. equity index family for institutional investors, with 26 indexes and over $3.8 trillion in investment assets benchmarked against them. Russell's global indexes offer an objective and transparent way to accurately measure distinct segments of the global market. Approximately 10,000 companies or 98 percent of companies globally find their place in this benchmark.” "We are pleased to be included in the Russell Microcap Index as it provides market participants new opportunities to own shares of IntegraMed through an additional investment vehicle,” commented Jay Higham, President and CEO of IntegraMed America, Inc. About IntegraMed America, Inc. IntegraMed America, Inc. provides business services to a national network of 30 fertility centers in 86 locations across the United States; distributes pharmaceutical products and treatment financing programs directly to consumers; and operates the Web site http://www.integramed.com, a leading fertility portal. The IntegraMed network includes 153 physicians and Ph.D. scientists. Network membership is limited to one practice per metropolitan area, yet one of every five procedures in the U.S. is performed in an IntegraMed practice. IntegraMed provides more services to both consumers and medical providers in the fertility field than any other consortium. Statements contained in this press release that are not based on historical fact, including statements concerning future results, performance, expectations and expansion of IntegraMed are forward-looking statements that may involve a number of risks and uncertainties. Actual results may differ materially from the statements made as a result of various factors, including, but not limited to, the risks associated with IntegraMed’s ability to finance future growth; the loss of significant business services contract(s); profitability at Reproductive Science Centers serviced by IntegraMed; changes in insurance coverage, government laws and regulations regarding health care or managed care contracting; and other risks, including those identified in the company’s most recent Form 10-K and in other documents filed by IntegraMed with the U.S. Securities and Exchange Commission. All information in this press release is as of June 27, 2007 and IntegraMed undertakes no duty to update this information.